ZEB1 and breast carcinoma: LINC00894 enhances cell proliferation and invasion by binding with miR-429 to mediate ZEB1 expression in breast cancer (Meng, Shao & Feng, 2021); what’s more, in thyroid cancer, its increased expression reduces the oncogenic properties by sponging let-7e−5p to promote TIA-1 expression (Chen et al., 2022a).